Trial Profile
A randomized, open-label, single-dosing, crossover study to compare the safety and pharmacokinetic characteristics of TuNEX injection 25 mg with those of Enbrel injection 25 mg after subcutaneous injection in healthy male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- 14 Nov 2011 Results published in the Clinical Therapeutics.
- 26 Aug 2011 Actual initiation date (Mar 2007) added as reported by Korean Clinical Trials Register.
- 26 Aug 2011 New source identified and integrated (Korean Clinical Trials Register; KCT0000118).